For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
7
views
0
references
 Top references
cited by
10
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      222
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: not found

      Proposal of Japan Red Cross score for sorafenib therapy in hepatocellular carcinoma.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          There have been no established predictors of the outcome on sorafenib therapy for hepatocellular carcinoma (HCC) patients. We aimed to establish a new prognostic model suitable for sorafenib in HCC.

          Related collections

          Author and article information

          Journal
          Journal ID (iso-abbrev): Hepatol. Res.
          Title: Hepatology research : the official journal of the Japan Society of Hepatology
          Publisher: Wiley
          ISSN: 1386-6346
          ISSN (Print): 1386-6346
          Publication date (Electronic): Oct 2015
          Volume: 45
          Issue: 10
          Affiliations
          [1 ] Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Osaka, Japan.
          [2 ] Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
          [3 ] Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Musashino, Japan.
          [4 ] Center for Liver-Biliary-Pancreatic Diseases, Matsuyama Red Cross Hospital, Matsuyama, Japan.
          [5 ] Department of Gastroenterology and Hepatology, Takamatsu Red Cross Hospital, Takamatsu, Japan.
          [6 ] Department of Gastroenterology, Japanese Red Cross Medical Center, Tokyo, Japan.
          [7 ] Department of Gastroenterology and Hepatology, Nagoya Daini Red Cross Hospital, Nagoya, Japan.
          [8 ] Department of Gastroenterology, Matsue Red Cross Hospital, Matsue, Japan.
          Article
          DOI: 10.1111/hepr.12480
          PubMed ID: 25581351
          SO-VID: 6083801d-7156-4554-b40d-65ff788a8c1c
          History

          Keywords: survival,hepatocellular carcinoma,predictive factor,prognostic model,sorafenib
          Data availability:
          Keywords: survival, hepatocellular carcinoma, predictive factor, prognostic model, sorafenib

          Comments

          Comment on this article

          scite_

          Similar content222

          See all similar

          Cited by10

          See all cited by